Test-Retest Brain Imaging Study

Posted to the HDL: 17 May 2006

Test-Retest Brain Imaging Study

Dr Adam Aron

Los Angeles area people who are gene-positive for Huntington’s disease, yet currently presymptomatic, are wanted for a test-retest brain imaging study. Must be between 18 and 55 years old, right-handed, competent English speaker. The study involves a 1.5 hour MRI scan on two occasions (separated by one year). Volunteers must visit UCLA for a screening session in advance of MRI participation. Volunteers will earn $20 per hour for their participation. For further information contact Dr Adam Aron at (310) 206-4379 and mention the “test-retest study” or send email to: study@poldracklab.org with ‘test-retest study’ in the subject line. # # #

Source: UCLA

printer friendly
version




	Read the HDAC/HDLighthouse Forum. Post your comments

Related Topics

Research focusing on the formation of aggregates caused by HD

Research related to the role Brain Derived Neurotrophic Factor has on the pathology of HD in the brain

Research related HD and it's general affect on the brain

Learn more about the clinical trial process, trials that have been conducted and those that are underway.

Research related to drugs and supplements that may delay onset and slow progression of Huntington's Disease.

Research focusing on gene therapy.

Research focusing on gene transcription.

Research studying the genetics of Huntington's Disease

Research studying the Immune System and it's effect on the progression of HD

Research studying the brain tissue and research related to stem cells

Recent Updates

22 Dec 2009

Here is an opportunity to tell the medical professionals about quality of life issues.

6 Dec 2009

A trial of mesenchymal stem cell is planned for the end of 2010.

5 Dec 2009

Preclinical work supports the use of mesenchymal stem cells to treat neurodegenerative disorders.

5 Dec 2009

The search for genetic modifiers is an important part of the effort to find treatments.

20 Sep 2009

Researchers have identified the mechanism by which axonal transport is impaired in neurons in HD.

4 Jul 2009

Researchers at Johns Hopkins have discovered that a protein called rhes binds to the HD protein and causes toxicity.

24 Apr 2009

MSG-MIND researchers discover a new therapeutic target: increased acetylation enhances clearance of the HD ptotein from the nucleus.

31 Jan 2009

Cell model study shows that impaired ERAD and ER stress are early and specific events in polyglutamine toxicity.

22 Jan 2009

Variations in the PGC-1 alpha gene delay onset in HD, suggesting a target for treatment.

22 Jan 2009

Researchers find a metabolic problem in the HD mice and confirm downregulation of the PGC-1 alpha gene in human patients.

All Updates for


	Disclaimer & Privacy Policy \| Welcome \| Site Feedback Marsha@HDLighthouse.org